(Q33947964)

English

The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes (English)

1 reference

Europe PubMed Central

30 July 2017

myasthenia gravis

0 references

author name string

M Paas-Rozner

1

1 reference

Europe PubMed Central

30 July 2017

M Sela

2

1 reference

Europe PubMed Central

30 July 2017

E Mozes

3

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

16 October 2001

1 reference

Europe PubMed Central

30 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

30 July 2017

98

1 reference

Europe PubMed Central

30 July 2017

22

1 reference

Europe PubMed Central

30 July 2017

12642-12647

1 reference

Europe PubMed Central

30 July 2017

Certified professionals: CD4(+)CD25(+) suppressor T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Attenuation of inducible Th2 immunity with autoimmune disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Fine specificity of T cell lines and clones that are capable of inducing autoimmune manifestations in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

T helper function of CD4+ cells specific for defined epitopes on the acetylcholine receptor in congenic mouse strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=60107

5 July 2018

Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Tolerance induction by acylated peptides: suppression of EAE in the mouse with palmitoylated PLP peptides

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivity

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Myasthenia gravis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Analysis of the biological functions and fine specificity of (T,G)-A--L specific T cell clones

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Induction of Interferon-γ, Interleukin-4, and Transforming Growth Factor-β in Rats Orally Tolerized against Experimental Autoimmune Myasthenia Gravis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Altered tumor growth factor beta mRNA expression is associated with thymectomy-related clinical remission in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Increased levels of circulating acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for myasthenia gravis (MG)

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Oral Tolerance to Myelin Basic Protein Induces Regulatory TGF-β-Secreting T Cells in Peyer's Patches of SJL Mice

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.221456798

21 January 2018

Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/11606745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent

1 reference

https://pubmed.ncbi.nlm.nih.gov/11606745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit

1 reference

https://pubmed.ncbi.nlm.nih.gov/11606745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myasthenia gravis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11606745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.221456798

1 reference

Europe PubMed Central

30 July 2017

2001PNAS...9812642P

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33947964&oldid=1768885930"